Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on May 12, 2025

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
NEWTOWN, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for improving balance and gait deficits and …

Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Phase 2b SYMMETRY study preliminary results showed statistically significant reversal of compensated cirrhosis (F4) due to MASH following 96 weeks of treatment with efruxifermin (EFX) Presented two oral presentations and a poster presentation highlighting …

Aya Gold & Silver Secures US$25 Million Credit Facility from EBRD to Support Growth in Morocco
MONTREAL, May 12, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that it has received final internal approval by the Board of Directors of the European Bank for Reconstruction …

Wag! Reports First Quarter 2025 Results
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co. (the “Company” or “Wag!”; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced financial …

New Wave Announces Shares for Debt Settlements
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (the “Company” or “New Wave”) (CSE: NWAI, FWB: 0XM0, OTCPK: TRMNF) announces the Company has entered into debt settlement agreements for an aggregate of $348,640 in debt …

BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Enrollment complete in SERENITY At-Home pivotal Phase 3 safety trial for acute treatment of agitation associated with bipolar disorders or schizophrenia Topline data expected in second half of 2025 intended to support potential sNDA submission for label …

AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
MILAN, May 12, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announces the presentation of two …

U.S. Energy Corp. to Participate in the D. Boral Capital Inaugural Global Conference
HOUSTON, May 12, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corp (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing assets, announced today that it will participate in the D. …

Precore Gold Announces Nomination of Louis Gariepy to Its Board of Directors, Completion of the Arikepay Agreement and Granting of Stock Options
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce the nomination of Mr. Louis Gariepy, P. Eng (OIQ) for election to its Board of Directors at the Company's …

EnviroGold Global Consolidates Process Development Technology and Strengthens IP Portfolio with New Patent Filing
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a clean technology company reprocessing mine waste to produce precious and critical metals, unlocking significant …

Viasat's Arctic Broadband Dedicated Coverage Advances as Payloads Enter Service Onboard Space Norway’s Arctic Satellite Broadband Mission Spacecraft
CARLSBAD, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, has confirmed the GX10A and GX10B satellite payloads are now available to deliver services for government customers, with …

Tiziana Life Sciences Announces Purchase of Shares by Chairman
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully …

Kaspi.kz 1Q 2025 Financial Results
ALMATY, Kazakhstan, May 12, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 65.41% of Hepsiburada in Türkiye, today published its unaudited …

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an underwritten offering of 76,923,076 …

Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4
ZUG, Switzerland, May 12, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such …

Fortrea Reports First Quarter 2025 Results
For the three months ended March 31, 2025, from continuing operations: Revenues of $651.3 million GAAP net loss of $(562.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $30.3 million GAAP and adjusted net (loss) income per …

Fortrea Announces CEO Stepping Down
DURHAM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that Thomas Pike is stepping down from his role as Fortrea’s Chief Executive Officer and as …

Falco Files Requested Documentation for the Horne 5 Project’s Environmental Authorization Process
MONTRÉAL, May 12, 2025 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX.V: FPC) ("Falco" or the "Corporation") is pleased to announce that it has responded to all questions and comments requested by the Direction de l'évaluation environnementale ("DEE") des …

Processus d’autorisation environnementale du projet Horne 5 : Falco dépose la documentation demandée
MONTRÉAL, 12 mai 2025 (GLOBE NEWSWIRE) -- Ressources Falco Ltée (TSX.V : FPC) (« Falco » ou la « Société ») a le plaisir d’annoncer avoir répondu à l’ensemble des questions et commentaires demandés par la Direction de l’évaluation environnementale (« DEE …

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)
- 28% confirmed response rate (5/18) per RECIST v1.1 in unselected patients across doses prioritized for expansion (7.2, 8.6 and 10 mg/kg Q3W) - - 3 of 7 evaluable patients (43%) with confirmed responses at upper expansion dose (10 mg/kg Q3W) - - Median …